Wave Life Sciences is a clinical-stage RNA medicines company committed to delivering life-changing treatments for people battling diseases
Wave Life Sciences has raised $350.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in December 2025.
Wave Life Sciences's investors include RA Capital Management, Cormorant Asset Management, Redmile Group, Foresite Capital, Teva Pharmaceuticals.
Wave Life Sciences is headquartered in Boston, United States.
Wave Life Sciences is a clinical-stage RNA medicines company committed to delivering life-changing treatments for people battling diseases
Wave Life Sciences is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Wave Life Sciences — Funding & Investors." VCBacked, December 9, 2025, https://www.vcbacked.co/company/wave-life-sciences. Accessed July 19, 2026.
VCBacked. (2025). Wave Life Sciences — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/wave-life-sciences
{{cite web |title=Wave Life Sciences — Funding & Investors |url=https://www.vcbacked.co/company/wave-life-sciences |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated